Gurit Holding Valuation

Is 0QQR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0QQR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CHF 72.18
Fair Value
75.1% undervalued intrinsic discount
3
Number of Analysts

Below Fair Value: 0QQR (CHF18) is trading below our estimate of fair value (CHF72.18)

Significantly Below Fair Value: 0QQR is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0QQR?

Key metric: As 0QQR is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0QQR. This is calculated by dividing 0QQR's market cap by their current revenue.
What is 0QQR's PS Ratio?
PS Ratio0.2x
SalesCHF 428.71m
Market CapCHF 81.74m

Price to Sales Ratio vs Peers

How does 0QQR's PS Ratio compare to its peers?

The above table shows the PS ratio for 0QQR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
IOF Iofina
1.1x13.3%UK£44.1m
SYNT Synthomer
0.1x3.2%UK£245.4m
TET Treatt
1.6x6.0%UK£246.1m
CAR Carclo
0.1x9.7%UK£16.6m
0QQR Gurit Holding
0.2x0.6%CHF 81.7m

Price-To-Sales vs Peers: 0QQR is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (0.7x).


Price to Sales Ratio vs Industry

How does 0QQR's PS Ratio compare vs other companies in the GB Chemicals Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.1.1x-3.9%
0QQR Gurit Holding
0.2x0.6%US$89.82m
JMAT Johnson Matthey
0.2x-31.5%US$2.95b
SYNT Synthomer
0.1x3.2%US$304.06m
0QQR 0.2xIndustry Avg. 1.1xNo. of Companies6PS01.22.43.64.86+
7 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.1x15.2%
0QQR Gurit Holding
0.2x92.4%US$89.82m
No more companies

Price-To-Sales vs Industry: 0QQR is good value based on its Price-To-Sales Ratio (0.2x) compared to the UK Chemicals industry average (1.2x).


Price to Sales Ratio vs Fair Ratio

What is 0QQR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0QQR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: 0QQR is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0QQR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 18.00
CHF 21.33
+18.5%
30.9%CHF 30.00CHF 14.00n/a3
Feb ’26CHF 19.18
CHF 21.33
+11.2%
30.9%CHF 30.00CHF 14.00n/a3
Jan ’26CHF 15.20
CHF 24.67
+62.3%
45.1%CHF 40.00CHF 14.00n/a3
Dec ’25CHF 11.50
CHF 24.67
+114.5%
45.1%CHF 40.00CHF 14.00n/a3
Nov ’25CHF 19.02
CHF 44.67
+134.8%
14.8%CHF 54.00CHF 40.00n/a3
Oct ’25CHF 26.40
CHF 54.67
+107.1%
22.4%CHF 70.00CHF 40.00n/a3
Sep ’25CHF 35.00
CHF 54.67
+56.2%
22.4%CHF 70.00CHF 40.00n/a3
Aug ’25CHF 44.00
CHF 75.00
+70.5%
14.4%CHF 90.00CHF 65.00n/a3
Jul ’25CHF 53.20
CHF 81.25
+52.7%
17.6%CHF 100.00CHF 65.00n/a4
Jun ’25CHF 59.70
CHF 87.80
+47.1%
13.4%CHF 100.00CHF 70.00n/a5
May ’25CHF 60.10
CHF 87.80
+46.1%
13.4%CHF 100.00CHF 70.00n/a5
Apr ’25CHF 66.40
CHF 86.83
+30.8%
12.0%CHF 100.00CHF 75.00n/a6
Mar ’25CHF 67.90
CHF 86.83
+27.9%
12.0%CHF 100.00CHF 75.00n/a6
Feb ’25CHF 75.16
CHF 88.00
+17.1%
10.7%CHF 100.00CHF 77.00CHF 19.186
Jan ’25CHF 81.60
CHF 91.50
+12.1%
10.2%CHF 100.00CHF 77.00CHF 15.206
Dec ’24CHF 72.60
CHF 91.50
+26.0%
10.2%CHF 100.00CHF 77.00CHF 11.506
Nov ’24CHF 70.60
CHF 91.50
+29.6%
10.2%CHF 100.00CHF 77.00CHF 19.026
Oct ’24CHF 93.20
CHF 102.83
+10.3%
21.8%CHF 150.00CHF 80.00CHF 26.406
Sep ’24CHF 87.90
CHF 102.57
+16.7%
20.3%CHF 150.00CHF 80.00CHF 35.007
Aug ’24CHF 93.40
CHF 101.00
+8.1%
21.0%CHF 150.00CHF 80.00CHF 44.007
Jul ’24CHF 83.16
CHF 101.17
+21.6%
22.7%CHF 150.00CHF 80.00CHF 53.206
Jun ’24CHF 83.70
CHF 101.17
+20.9%
22.7%CHF 150.00CHF 80.00CHF 59.706
May ’24CHF 90.00
CHF 101.17
+12.4%
22.7%CHF 150.00CHF 80.00CHF 60.106
Apr ’24CHF 82.81
CHF 102.43
+23.7%
21.0%CHF 150.00CHF 80.00CHF 66.407
Mar ’24CHF 98.19
CHF 111.00
+13.0%
15.9%CHF 150.00CHF 96.00CHF 67.907
Feb ’24CHF 99.57
CHF 112.29
+12.8%
15.2%CHF 150.00CHF 96.00CHF 75.167
Analyst Price Target
Consensus Narrative from 3 Analysts
CHF 21.97
Fair Value
18.1% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 22:31
End of Day Share Price 2025/02/07 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Gurit Holding AG is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrick RafaiszBank Vontobel AG
Rupesh MadlaniBarclays
Michael HeiderBerenberg